Comparison 2. Pregabalin versus placebo: safety.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
2.1 Withdrawals | 1 | Risk Difference (M‐H, Fixed, 95% CI) | Subtotals only | |
2.1.1 Number of withdrawals | 1 | 22 | Risk Difference (M‐H, Fixed, 95% CI) | ‐0.09 [‐0.48, 0.30] |
2.1.2 Withdrawal due to adverse events | 1 | 22 | Risk Difference (M‐H, Fixed, 95% CI) | 0.18 [‐0.13, 0.50] |
2.1.3 Withdrawals for other reasons | 1 | 22 | Risk Difference (M‐H, Fixed, 95% CI) | ‐0.27 [‐0.55, 0.01] |
2.2 Adverse events | 1 | 22 | Risk Difference (M‐H, Fixed, 95% CI) | 0.18 [‐0.13, 0.50] |